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AbstrACt
Introduction Prenatal and neonatal environmental 
factors, such as nutrition, microbes and toxicants, may 
affect health throughout life. Many diseases, such 
as allergy and impaired child development, may be 
programmed already in utero or during early infancy. Birth 
cohorts are important tools to study associations between 
early life exposure and disease risk. Here, we describe the 
study protocol of the prospective birth cohort, ‘Nutritional 
impact on Immunological maturation during Childhood in 
relation to the Environment’ (NICE). The primary aim of the 
NICE cohort is to clarify the effect of key environmental 
exposures—diet, microbes and environmental 
toxicants—during pregnancy and early childhood, on 
the maturation of the infant’s immune system, including 
initiation of sensitisation and allergy as well as some 
secondary outcomes: infant growth, obesity, neurological 
development and oral health.
Methods and analysis The NICE cohort will recruit about 
650 families during mid-pregnancy. The principal inclusion 
criterion will be planned birth at the Sunderby Hospital in 
the north of Sweden, during 2015–2018. Questionnaires 
data and biological samples will be collected at 10 time-
points, from pregnancy until the children reach 4 years 
of age. Samples will be collected primarily from mothers 
and children, and from fathers. Biological samples include 
blood, urine, placenta, breast milk, meconium, faeces, 
saliva and hair. Information regarding allergic heredity, diet, 
socioeconomic status, lifestyle including smoking, siblings, 
pet ownership, etc will be collected using questionnaires. 
Sensitisation to common allergens will be assessed by 
skin prick testing and allergic disease will be diagnosed 
by a paediatrician at 1 and 4 years of age. At 4 years of 
age, the children will also be examined regarding growth, 
neurobehavioural and neurophysiological status and oral 
health.
Ethics and dissemination The NICE cohort has been 
approved by the Regional Ethical Review Board in Umeå, 
Sweden (2013/18-31M). Results will be disseminated 
through peer-reviewed journals and communicated on 
scientific conferences.
IntroduCtIon  
The fetal and neonatal periods could be 
regarded as a window of opportunity for 
influencing health during childhood and 
throughout life. Environmental exposures, 
such as nutrition, microbiota and toxi-
cants and genetic or epigenetic factors may 
synergise to impact growth, neurodevelop-
ment and immune maturation. However, 
which factors are most important and the 
mechanisms by which they operate are still 
poorly understood. The Nutritional impact 
on Immunological maturation during 
Childhood in relation to the Environment 
(NICE) cohort focuses primarily on early life 
strengths and limitations of this study
 ► Prospective study design covering a period from 
mid-pregnancy to the age of 4 years with biological 
samples from both the mother, father and child for 
evaluation of microbiology, nutrition, immunology, 
environmental toxicants, genetics and epigenetics.
 ► Interdisciplinary, translational approach and ad-
vanced analytical methods within the field of al-
lergology, immunology, nutrition, microbiology, 
toxicology, obstetrics, childhood growth, neurophys-
iological development and oral health.
 ► The primary outcome, allergic disease (food allergy, 
atopic eczema, asthma and allergic rhinoconjuncti-
vitis) is diagnosed by a paediatric allergology spe-
cialist according to strictly defined protocols.
 ► The large participant burden may also result in se-
lection bias and loss to follow-up.
 ► Although the study sample will allow in-depth anal-
yses of the effect of multiple exposures and genetic 
factors on several outcomes, these analyses may 
largely be exploratory and may require confirmation 
in follow up-studies.  o
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exposures, immune maturation and risk of immune-me-
diated diseases.
Allergy, dental caries and overweight are the most 
common chronic conditions in childhood, affecting the 
health and well-being of around 25%, 20% and 13% of 
children, respectively.1 Chronic diseases place a substan-
tial pressure on both the individual and on the healthcare 
system. Hence, it is important to explore how lifestyle, 
environmental and genetic/epigenetic factors during 
pregnancy and the first years of life protect against or 
facilitate the development of chronic diseases.
Allergy is characterised by dysregulation of the immune 
system leading to an incapacity to develop tolerance to 
normally harmless proteins in food and air. Decreased 
exposure to microorganisms and reduced complexity of 
the gut microbiota in early life have been associated with 
an increased risk for the development of allergy.2 3 Also, 
the diet of pregnant and lactating women4 and their expo-
sure to environmental toxicants5 6 have been suggested 
to play a role in immune maturation and allergy devel-
opment. In spite of extensive research in this area, the 
specific causes and pathways leading to immune matura-
tion, and their subsequent protective or detrimental influ-
ences on allergy development, remain largely unknown.
In order to identify the key factors leading to the devel-
opment of healthy immune regulation or allergic disease, 
it is necessary to study immune events at a very early age,7 
and account for external factors that could influence 
immune development. Allergy may present as early as a 
few months of age, usually manifested as atopic eczema 
or food allergy, while asthma and rhinoconjunctivitis 
generally appear at school age. A major source of impre-
cision in many studies on allergy development is the diag-
nostic methodology. While questionnaires are convenient 
and cost-effective, the diagnosis of childhood allergy by 
a skilled clinician, aided by tests of sensitisation, is the 
gold standard. For food allergy, a careful investigation 
of medical history by an experienced clinician, aided by 
elimination-provocation is the only method to adequately 
identify this type of allergic manifestation.
Multiple environmental factors, including diet and 
exposure to toxicants, may affect both the immune system 
and neurophysiological development.8–11 Nutritional 
factors considered to be immunomodulatory include 
unsaturated fatty acids, vitamins A and D, iron and zinc. 
Some nutrients as well as some metals pass the placenta 
to the fetus. Some metals accumulate in the placenta, 
thus elemental metals may cause both impaired placental 
function and fetal toxicity. Even low-level exposure to 
certain metals, for example, cadmium (Cd), arsenic 
(As), manganese (Mn) and lead (Pb), has been found to 
impair fetal and childhood immune function, growth and 
neurodevelopment.12–15
Overweight and obesity are increasing worldwide. 
Overweight at a young age is an important risk factor 
for obesity later in life. In Sweden, obesity has increased 
during the last 40 years from 2.3% to 4.7% among girls 
and from 2.6% to 8.5% among boys.16 Socioeconomic 
status and physical activity are important determinants, 
but there are other factors to explore such as the impact 
of different dietary components (eg, fatty acids) and envi-
ronmental toxicants, metabolic processes and epigenetic 
factors, to name just a few.
In Western countries, one-fifth of children are so-called 
high-caries cases (children with a high burden of dental 
caries) that do not respond to traditional prevention.17 
These high-caries cases derive from an immune deficiency 
or carriage of high virulence strains of Streptococcus mutans, 
consistent with their non-responder behaviour.18 19 By 
contrast, the low-to-moderate risk children develop caries 
as expected from eating and oral hygiene habits.18 There-
fore, the NICE study aims to evaluate the oral health of all 
participating children in order to better understand the 
link between impaired immune maturation and the risk 
for caries development.
AIMs And objECtIvEs
Primary aim
The primary aim of the NICE birth cohort is to evaluate 
how multiple environmental exposures such as lifestyle, 
diet, microbes and toxicants influence maturation of the 
immune system and affect allergy development.
secondary aim
The secondary aim of NICE is to examine if these same 
environmental exposures influence pregnancy outcomes, 
childhood growth, obesity, neuropsychological develop-
ment and caries development.
research questions
The NICE cohort has been designed to answer the 
following research questions:
i. Which nutrients affect the maturation of the in-
fant’s immune system, allergy development, oral 
health, neurophysiological development, growth and 
obesity?
ii. Can a metabolic fingerprint be identified that pre-
dicts disease risk during childhood?
iii. What role do the oral and gut microbiota play in im-
munological maturation, allergy development, oral 
health, neurophysiological development, growth and 
obesity?
iv. What is the impact of early life exposure to toxicants, 
particularly toxic metals, on immune maturation, al-
lergy development, caries diseases, neurophysiologi-
cal development, growth and obesity?
v. Does maturation of the immune system during fetal 
life and infancy affect the risk of allergy development, 
oral health or neurophysiological development?
vi. Can certain immune signatures be identified that are 
associated with immune dysregulation, caries devel-
opment or, conversely, with health?
vii. Is early life exposure to toxic metals and essential ele-
ments reflected in the dental enamel?
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viii. Which nutritional, environmental and lifestyle pro-
files are protective against caries in the high versus 
the low-to-moderate caries risk groups and types?
ix. What is the impact of nutrition and toxic exposures 
on the epigenetic programming of children in rela-
tion to immune maturation, allergy development, 
oral health, neurophysiological development, growth 
and obesity?
x. What are the effects of perinatal exposures (diet, 
lifestyle and environmental toxicants) on pregnancy 
outcomes such as gestational diabetes, pre-eclamp-
sia, pregnancy length, intrauterine growth and birth 
weight?
MEthods And AnAlysIs
study design and setting
The study design is a prospective longitudinal birth 
cohort study. All expectant parents planning to give birth 
at the Sunderby Hospital in Luleå, during 2015–2018, 
will be invited to participate. The Sunderby Hospital, 
with approximately 2000 deliveries per year, is located 
in Region Norrbotten in the very north of Sweden. 
Region Norrbotten makes up almost a quarter of Sweden 
geographically, but has a population of only approxi-
mately 250 000 inhabitants. Expectant mothers are cared 
for at 22 maternity clinics across the region. Routine ultra-
sound is performed at gestational week 18–19 at either 
of three sites: at the Sunderby, Kalix or Piteå hospitals. 
These three hospitals have combined catchment area of 
approximately 200 000 inhabitants.
recruitment and inclusion and exclusion criteria
All expectant parents living in the catchment area of the 
Sunderby Hospital will receive a concise information 
leaflet about the study at their first visit to their local 
maternity clinic in gestation week 10–12. Recruitment will 
take place in connection with the routine ultrasound at 
gestational week 18–19. All expectant parents will be given 
detailed information about the study. The parents who 
wish to participate will be requested to provide informed 
consent. They will subsequently receive an acknowledge-
ment letter and will be assigned a study ID number.
The criteria for participation in the study will be as 
follows: the intention to give birth at the Sunderby 
Hospital, the ability to communicate in written and 
spoken Swedish and current habitation in Region Norr-
botten. Families will be excluded from the study if they 
move from Norrbotten before the child is born. Families 
who move outside of Norrbotten after birth will be allowed 
to continue participation in the study if so wished and 
follow-up appointments will be arranged where possible.
Estimated sample size
The NICE cohort will be based on the conservative 
inclusion of children to be delivered at the Sunderby 
Hospital with run-in during the period 15 January 2015 
to 28 February 2018 (table 1). The aim is to include 650 
families. Assuming 25% allergy rate among 650 families, 
we estimate the effects that can be detected with 80% 
power and 5% significance level in univariate analysis of 
marginal effects. For continuous variables, an effect size 
(Cohen's d) of 0.25 can be detected and for dichotomous 
exposures ranging in prevalence among allergic patients 
(5%, 10%, 20%, 50%), the corresponding ORs that can 
be detected are 5.3, 2.9, 2.0 and 1.7, respectively.
study outcomes
Primary outcome
The primary outcome in NICE is immune maturation 
in the neonatal period and its effect on development of 
sensitisation and allergy over a follow-up period of 4 years.
Secondary outcomes
The secondary outcomes are:
Pregnancy outcomes (pre-eclampsia, gestational dia-
betes, gestational week at birth, intrauterine growth 
and birth weight).
Child growth (including overweight and obesity).
Neurophysiological development (test of motor, cog-
nitive and behavioural function).
Caries and oral health.
biological sample collection
Mothers, fathers and infants participating in the NICE 
cohort will be repeatedly followed up from pregnancy 
until 4 years of age with both questionnaires and biolog-
ical sample collection (figure 1). Mothers will fill out 
questionnaires and/or give biological samples at gesta-
tional week 18, 28 and 34, at delivery and at 1, 4 and 12 
months post partum. Fathers will fill out questionnaires 
Table 1 Overview of the NICE study recruitment and follow-up
2014 2015 2016 2017 2018 2019 2020 2021 2022
Project start, planning
Recruitment of patients
Children born
12 months follow-up
48 months follow-up
Data collection
NICE, Nutritional impact on Immunological maturation during Childhood in relation to the Environment.
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and/or give biological samples at gestational week 18 and 
48 hours and 12 months post partum. All children will be 
followed up with biological samples or clinical examina-
tions at birth and at 48 hours, 4, 12, 18 and 48 months of 
age. The flow chart of the study is shown in figure 1 and 
a detailed overview of the collection of biological samples 
and questionnaires is shown in table 2.
Subcohort
Approximately one in four recruited families will be 
offered the possibility to participate in a subcohort with 
more extensive sampling of mother and infant (table 2). 
Mothers and children in the subcohort will be followed 
up additionally at 1 month of age. Also, children in the 
subcohort will collect faeces samples at weeks 1, 2, 4 and 
6 and at months 4 and 6. The assignment of families to 
the subcohort will be performed at delivery, based on the 
feasibility of extended sampling at that timepoint.
Blood samples
Blood samples collected from the parents will include: 
10 mL/5 mL SST II Advance serum tube, 10 mL/3 mL 
EDTA tube (all from Becton Dickinson, Plymouth, 
UK), 6 mL Na-heparin trace element-free tube (Greiner 
bio-one, Kremsmünster, Austria) and 10 mL RNA-stabi-
lised blood collection Tempus tubes (Applied Biosystems, 
Foster City, California, USA), the latter from mothers 
only. The mothers will be asked to be fasting for 8 hours 
before study visits.
At birth, venous and arterial cord blood will be collected 
from the umbilical cord into small 500 µL Microtainer 
EDTA tubes (Becton Dickinson) using a syringe. Mixed 
umbilical cord blood will be collected into another 3 and 
6 mL EDTA tubes (the 3 mL tube will be stored at room 
temperature for subsequent flow cytometric analysis) 
and a 6 mL Na-heparin trace element-free tube (Greiner 
bio-one). Midwives will follow WHO guidelines with 
regard to umbilical cord clamping, that is, cord clamping 
will be carried out >1 min after the birth or when cord 
pulsation has ceased.
Venous blood will be collected from the infants by the 
study nurses into 3 mL EDTA tubes (Becton Dickinson) 
using a Microneedle (Sarstedt, Nümbrecht, Germany) 
or Eclipse Signal Blood Collection needle (Becton Dick-
inson). Blood will be drawn from the dorsal side of the 
hand at 48 hours, 1 month, 4 months and from the hand 
or arm at 12 and 48 months of age.
Urine samples
Infant’s urine at 4 months of age will be collected in a 
urine collection bag placed around the penis or vagina 
under the infant’s nappy at the start of a study visit, with 
the bag being collected at the end of the study visit. Urine 
samples at 4 years of age will be collected in a potty lined 
with a plastic bag. Midstream urine samples, taken at a 
random timepoint during the day, will be collected from 
adults.
Placenta
After delivery, the placenta will be examined according 
to local guidelines by the delivery personnel and placed 
in a plastic bag and stored at 4°C. The placenta will be 
collected by the study nurses and processed at the labora-
tory as outlined in figure 2.
Breast milk
Mothers will be asked to express 30 mL of breast milk in 
the morning before the second breastfeeding occasion of 
the day, at 1 and 4 months post partum. Samples will be 
collected in a clean bowl or pump and poured into plastic 
centrifuge tubes for immediate storage at −20°C at home. 
Mothers will be requested to bring the frozen tubes with 
them at the 4 months follow-up and reminded to keep 
the samples in a cooling bag or wrapped in paper with a 
Figure 1 Flow chart of the NICE cohort. GW, 
gestational  week; NICE, Nutritional impact on Immunological 
maturation during Childhood in relation to the Environment.  on
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cooling block to prevent thawing of the samples during 
transport to the hospital. The samples will be transferred 
directly to a −80°C freezer on arrival to the research 
laboratory. If thawing appears to have occurred during 
transport, this will be noted in the sample preparation 
protocol.
Meconium
Meconium will be sampled when voided using a sterile 
spatula and put in a sterile container that will be imme-
diately stored at 4°C until aliquoting at the research 
laboratory.
Faeces
Faecal samples will be collected from the infant’s nappy 
by the parents at home using a sterile spatula. Faeces will 
be put in sterile tubes prelabelled with the child’s study 
ID. Parents will be requested to write the date of sampling 
on the tubes and then place the samples in the freezer 
as soon as possible and to bring it to the hospital at the 
next follow-up. Participants will be requested to keep the 
samples in a cooling bag or wrapped in newspaper to 
prevent thawing of the samples during transport to the 
hospital. The stool samples will be transferred directly to 
a −80°C freezer on arrival to the research laboratory. If 
thawing appears to have occurred during transport, this 
will be noted in the sample preparation protocol.
Saliva
Approximately 1.5–2 mL saliva will be collected from 
mothers, by spitting into a plastic tube. Infant saliva 
(approximately 0.5 mL) will be collected from the buccal 
cavity using a plastic Pasteur pipette.
Buccal swabs
Buccal swabs (eSwab, Copan, Bresia, Italy) will be collected 
by swiping the swab tip pass beneath the upper lip, and 
the inside of the cheeks, taking care to avoid touching the 
teeth. The swabs will be stored at 4°C until centrifugation 
at 12 000 g for 10 min. Excess fluid will be removed from 
the bacterial pellet before storage.
Hair specimens
At 48 months, hair specimens will be cut by stainless steel 
scissors from the occipital part of the head, beneath some 
covering hair, as close to the scalp as possible.
Figure 2 Schematic overview of placenta collection at delivery. Samples from the placenta will be collected for analysis of 
histology, DNA, RNA, proteins, metabolomics, fatty acids, toxicants and essential elements. First four pieces, 4 cm3 of villous 
tissue including decidua will be collected from the basal plate from four separate places of the placenta. The decidua will be 
removed stored in a separate cryo-tube. The remaining villous tissue will be divided into 20 smaller pieces, 4 pieces of 3 mm 
Ø that will be put in RNAlater and 16 pieces that will be put 4 and 4 in separate cryo-tubes. Two different cross-sections will 
be then collected: one cross-section measuring approximately 2×2 cm taken within 4 cm from the cord insert will be placed in 
formalin. Another cross-section formed as a V taken from the cord insert to the end of the placenta will be sampled with specific 
metal-free ceramic knife and put into plastic bags. The cross-sections will be taken with care to avoid selecting a tissue section 
that has previously been sampled for villous tissues. At 1 cm from the cord insert, a 2 cm piece of the umbilical cord will be 
sampled and stored in formalin. From the same end of the cord, two pieces, 1 cm each in length, will be sampled and placed in 
a cryo-tube. Also, samples from the membrane will be collected: pieces of the amnion and chorion membranes will be placed in 
separate cryo-tubes, while one piece of membrane with both the membranes still attached to each other (‘double membrane’) 
will be placed in formalin.
 o
n
 21 O
ctober 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-022013 on 21 October 2018. Downloaded from 
8 Barman M, et al. BMJ Open 2018;8:e022013. doi:10.1136/bmjopen-2018-022013
Open access 
handling, transport and storage of biological samples
At gestational week 28, samples will be collected at the 
maternity clinics. The RNA Tempus blood samples and 
urine samples will be stored immediately at 4°C, while 
blood samples will be kept at room temperature for 
30 min before centrifugation. All samples will be stored at 
4°C until transport and will be subsequently transported 
at 4°C–10°C to the hospital laboratory, either the same 
day or the following work day.
Samples taken at delivery and at 48 hours will be stored 
at 4°C and processed within 2–12 hours if sampled on 
weekdays and within 12–65 hours if sampled on week-
ends. Samples taken at the follow-up visits at 1, 4, 12 and 
48 months of age will be collected by the NICE cohort 
study nurses and handled the same work day. All biolog-
ical samples will stand for 15–30 min in room temperature 
until centrifugation of the blood. After centrifugation of 
the blood, all samples will be stored at 4°C until aliquoting 
(performed on a cooling block) and interim storage at 
−20°C (for a maximum of 12 weeks). Once filled, storage 
boxes will be transferred to long-term storage at −80°C. 
Hair samples will be collected in paper envelopes and 
stored at room temperature. A laboratory protocol will 
be filled in for all samples where all transport and prepa-
ration times will be noted in order to be able to account 
for the time from sampling to freezer in all downstream 
analyses.
Collection of participant data
All study participants will be closely followed up during 
pregnancy from inclusion until the delivery from physi-
cian’s notes in their medical records. Data from the 
medical pregnancy records will be analysed and collected 
in the database.
At inclusion, both parents will be asked to fill out one 
online questionnaire each regarding allergic heredity and 
environment. When the infant has reached 18 months of 
age, the second online questionnaire, the ‘Infant envi-
ronment’ questionnaire, regarding the infant’s current 
living environment and lifestyle will be sent. The third 
online questionnaire, the ‘Child environment’ question-
naire will be sent out to the participants when the infant 
has reached 48 months of age and concerns the infant’s 
environment and lifestyle (tables 2 and 3).
Assessment of dietary intake in mothers and children
The mothers will receive a web-based, food frequency 
questionnaire (Meal-Q) by email during pregnancy in 
gestational week 34 and at 1 and 4 months post partum, 
consisting of questions regarding their diet during the 
previous month20 21 (tables 2 and 4). Reminders will be 
sent out by email 1 and 2 weeks after the initial email 
and, alongside the last reminder, a text message will be 
sent to their cell phones. The questionnaires will have a 
meal-based and interactive format, that is, only those who 
report a relevant frequency of consumption of a certain 
food or food group will receive follow-up questions, to 
promote ease of use and minimise the time required to 
answer the questionnaire. Depending on the number of 
follow-up questions, the Meal-Q questionnaire contains 
102–174 questions.
When the child reaches 12 and 48 months of age, the 
parents fill out a food frequency questionnaire about the 
infant’s food habits (TodMeal-Q and KidMeal-Q, respec-
tively), which will be similar to the Meal-Q but adopted 
for young children.22 Parents from families where both 
parents have attended the follow-up visits will be asked 
to participate in a subcohort with extended sampling, 
Table 3 Overview of questionnaires distributed in the NICE cohort
Questionnaire Time Answered by Questions about
Q1: ‘Allergic 
heredity and 
environment’
GW 20–25 Mothers and 
partners answer one 
questionnaire each
Education, profession, nationality, allergic heredity, smoking habits, 
alcohol habits, residence, heating, ventilation, ‘mould’, siblings, pets.
Q2: ‘Infant 
environment’
18 months Parents answers 
about the family
Questions to both parents regarding: profession, education, ethnicity, 
civil status, smoking habits, hunting habits, residence.
Questions about the infant: feeding, vaccinations, travels, daycare, 
behaviour, siblings, pets.
Q3: ‘Child 
environment’
48 months Parents answers 
about the family
Questions to both parents regarding: profession, education, civil 
status, smoking habits, hunting habits, residence
Questions about the infant: feeding, vaccinations, travels, daycare, 
behaviour, siblings, pets.
GW, gestational week; NICE, Nutritional impact on Immunological maturation during Childhood in relation to the Environment. 
Table 4 Overview of the dietary assessments and activity 
questionnaires in the NICE-cohort
Questionnaire Time Answered by
Meal-Q1+Active-Q1 GW 34 Mothers
Meal-Q2+Active-Q2 1 month Mothers
Meal-Q3+Active-Q3 4 months Mothers
TodMeal-Q+TodActive-Q 12 months Parents answer 
for the infant
KidMeal-Q+KidActive-Q 48 months Parents answer 
for the infant
GW, gestational week; NICE, Nutritional impact on Immunological 
maturation during Childhood in relation to the Environment.
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including a Meal-Q questionnaire for each of the parents 
at 12 months of age of the child.
To measure total energy expenditure, all dietary ques-
tionnaires will be combined with the activity question-
naires Active-Q23 or KidActive-Q.24
The questionnaires Meal-Q and KidMeal-Q have been 
validated in their original form,20–22 but all dietary ques-
tionnaires were modified to better fit the specific needs 
of the study of evaluation of fat quality, consumption of 
fish from polluted areas, sugar and probiotic use. Modifi-
cations are detailed in online supplementary file 1. Nutri-
tional composition of the diet will be calculated from 
the dietary questionnaires using the database of nutrient 
content published by the Swedish National Food Agency. 
The nutrient conversion for the questionnaires will be 
calculated by computer programs developed specifically 
for those questionnaires.
Diary for recoding introduction of complementary foods to the 
infant diet
Practices of introduction of complementary foods and 
formulas to the infant’s diet will be assessed each month 
during the first 12 months of life by a web-based question-
naire; ‘Infections and feeding’ (table 2). The questions 
include the infant’s intake of breast milk from breast 
or bottle, and whether certain foods have been intro-
duced, including formula (percentages of total feeding 
and brand name), gruel (regular, with/without gluten or 
lactose, soya based), porridge (regular, without gluten or 
lactose) and different food groups (potatoes/roots, fruit/
juice, berries, nuts/almonds, peanuts/peanut oil, bread/
crackers/cookies, butter, margarine, oil, milk, ice-cream, 
sour milk, yoghurt, meat, fish and egg), as well as if there 
are any food the child has started to eat more than twice 
per week that is not included above. Additional ques-
tions will be asked about probiotics, vitamin D, omega-3 
or other supplements and frequency of canned versus 
home-made food.
Parents will be asked to estimate the proportion of 
commercial versus home-made baby food. In order 
to be able to adjust the statistical analyses for reverse 
causation, the parents will be also asked the questions: 
‘during the past month, have you actively avoided to give 
any type of food due to concern of allergy?’ and ‘if so 
what food items have been excluded from the child’s 
diet?’
outcome measures
Infections during year 1
Infectious episodes will be recorded monthly by the 
parents during the first 12 months using the above-men-
tioned web-based questionnaire. If an infectious episode 
is recorded, follow-up questions will be posed concerning 
duration of the illness, body temperature, breathing 
problems, antibiotic treatment, medications, hospitalisa-
tion, etc.
Lung function test
Lung function will be assessed at 4 and 12 months, 
using respiratory resistance with interrupter technique 
(MicroRint, MicroMedical, UK). The method estimates 
alveolar pressure (Palv) by performing a rapid occlu-
sion of the airways during the respiratory circle at rest, 
assuming that Palv will equal mouth pressure (Pmo). 
Respiratory resistance with interrupter technique (RInt) 
is a non-invasive method that requires minimal cooper-
ation and can be used in evaluating airway obstruction 
in uncooperative and small children.25 26 At 48 months, 
lung function will be measured by standardised Impulse 
Oscillometry.
Skin prick test
Sensitisation to common allergens will be assessed by skin 
prick testing at 12 and 48 months of age. Testing will be 
performed on the volar side of the lower arm and will 
be carried out according to the standards of the Subcom-
mittee on Skin Tests of the European Academy of Allergy 
and Clinical Immunology.27 Six different standardised 
allergens (egg, milk, birch, timothy, cat and dog) will be 
applied with a lancet; histamine dihydrochloride (10 mg/
mL) will be used as positive control (Soluoprick, ALK 
Nordic A/S, Denmark). The test will be considered posi-
tive for a particular allergen if the mean weal diameter is 
at least 3 mm after 15 min.
Allergy diagnosis
Allergy will be diagnosed at 12 and 48 months by a 
specialist in paediatric allergology. The diagnosis will 
be based on a clinical history and a clinical examina-
tion using the same methodology as in the BAS cohort,28 
enabling direct comparisons. The clinical protocol will be 
carefully standardised and complies with the diagnostic 
protocols of our previous ALLERGYFLORA study29 and 
FARMFLORA study4.
The following diagnostic criteria will be used for clin-
ical allergic diagnosis at 12 and 48 months of age.
Atopic eczema, atopic dermatitis
Various diagnostic criteria for atopic dermatitis (AD) 
have been proposed and validated. For the NICE cohort 
follow-up at 12 and 48 months, we choose to employ the 
simplified criteria proposed by Williams et al with high 
sensitivity and specificity.30–32
 ► Major criteria (=must have): an itchy condition or 
parental report of scratching/rubbing by the child.
 ► Plus three or more of the following criteria: 1) personal 
history of itchiness in skin creases such as cheeks, 
folds of the elbows, behind knees, front of ankles or 
around the neck; 2) personal history of asthma or 
hay-fever or other atopic disease or a history of atopic 
disease among a first-degree relative; 3) a personal 
history of generally dry skin in the previous year; 4) 
visible eczema on the cheeks, folds of the elbows, 
behind knees, front of ankles or around neck; 5) a 
debut before 24 months of age.
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Food allergy
A diagnosis of food allergy requires a medical history of 
allergic reactions, on at least two consecutive occasions 
when eating a specific food allergen. The allergic reac-
tion disappears on elimination of the allergen. For early 
food reaction, allergic symptoms will appear <2 hours 
with rush, itching, urticaria, angioedema, gastrointes-
tinal pain, vomiting, oral symptoms, asthma or anaphy-
lactic reaction. Late food reaction (>2 hours) will present 
eczema, gastrointestinal reactions with pain, diarrhoea, 
obstipation and weight loss. For all suspected cases of 
food allergy, the diagnosis will be confirmed by elimi-
nation-provocation, that is, the child will be given the 
suspected food allergen and symptoms will be recorded. 
The elimination-provocation procedure will be carried 
out at home following local guidelines if the symptoms 
are mild. If this is not feasible, or if the case is unclear, 
the child will be admitted to the paediatric ward at the 
Sunderby Hospital for repeated open food provocation 
until the diagnosis is clarified (food allergic or healthy). 
Open provocation will start with a dose determined by 
the individual child’s food allergen reaction and will be 
followed by increasing doses of specific food allergen 
given with 30 min interval in three to five steps. The child 
will stay at the ward for 2 hours after the last dose and 
parents will thereafter report any symptoms during the 
following days.
Allergy to animals
A diagnosis of allergy to animal dander requires a 
medical history of symptoms from the eyes and/or nose 
and/or asthma on at least two consecutive occasions 
when exposed to a specific animal dander (eg, dog, cat, 
rabbit, horse). The reaction disappears when the animal 
allergen is removed.
Pollen allergy
A diagnosis of pollen allergy requires a medical history 
of symptoms from eyes and/or nose and/or asthma on 
two consecutive occasions when exposed during pollen 
season. The reaction disappears in areas with lower pollen 
content or following medication.
Asthma
At 12 months, an asthma diagnosis requires at least one of 
the following: 1) the presence of wheeze between infec-
tions, 2) persistent wheeze for at least 4 weeks, 3) at least 
one period of wheeze during an infectious disease with 
concomitant allergic disease (AD, food allergy or allergic 
rhinoconjunctivitis) or 4) three episodes of wheeze 
during infectious disease, with no concomitant allergic 
disease.
At 48 months, an asthma diagnosis requires at least one 
of the following: the presence of 1) wheeze within the last 
12 months (during or between infections) or 2) ongoing 
controller medication.
If there is any doubt concerning the asthma diagnosis 
at 12 or 48 months, the child will be admitted to the 
children’s clinic at the Sunderby Hospital for a second 
clinical follow-up for doctor's diagnosed asthma.
Neuropsychological and neurobehavioural examination
At 48 months of age, the parents will be asked to answer 
questionnaires and the child will undergo examination 
with focus on neuropsychological behaviour. The ques-
tionnaires will consist of parent-reported Child Behaviour 
Checklist, Adaptive Behaviour Assessment System) and 
Social Responsiveness Scale. Cognitive development 
will be tested face-to-face with Wechsler Preschool and 
Primary Scale of Intelligence and a physical assessment of 
motor skills with Peabody Development Motor Scales (by 
a physiotherapist).
Oral health examination
Caries will be recorded in children at 48 months of age 
by one to three experienced and calibrated dentists 
(intra-examiner and interexaminer kappa ≥0.98) using 
a mirror and probe as the number of decayed (enamel 
caries included), filled surfaces in the primary dentition 
(defs).17–19 At the same visit, caries will also be recorded 
for the parents using two bitewing radiographs as the 
number of decayed (enamel caries included), filled 
surfaces in the permanent dentition (DeFS). Whole 
saliva and buccal swabs will be collected from the parents. 
Complementary questionnaires on oral behaviour data, 
such as oral hygiene, intake frequency of sweets and 
sugary drinks, use of fluorides and oral hygiene, will be 
taken for children and parents. Enamel discolourations 
and irregularities on visual inspection and probing will be 
registered and exfoliated primary teeth will be collected 
by parents in prepared tubes.
Analyses
Immune analysis
Blood samples will be analysed by flow cytometry regarding 
numbers and percentages of T and B cells and their subsets 
and their markers of naivety, activation and memory.33 34 A 
saliva sample will be collected from the mother close to the 
time of birth and from the infant at 4 months for the anal-
ysis of secretory IgA and salivary microbiota.35
Genetic analyses
Genomic DNA will be extracted from blood collected in 
EDTA tubes from mothers, fathers and infants for anal-
ysis of genetic variation. Blood will also be collected from 
the mothers in Tempus Blood RNA Tubes for stabilisation 
and isolation of total RNA from whole blood for gene 
expression analysis.
Metabolomics
To study metabolic alterations in the participants, non-tar-
geted metabolomics profiling will be employed on plasma 
samples by liquid chromatography mass spectrometry 
(LC-MS) and gas chromatography mass spectrometry 
(GC-MS) analysis.36
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Transcriptomics
Whole transcriptome analysis will be performed on 
placenta tissue from those placentas sampled within 
4 hours from birth and on maternal blood collected in 
Tempus RNA stabiliser tubes at gestation, at birth and 
during lactation.
Total RNA will be analysed and its quality will be 
checked using a bioanalyser. RNA microarray analysis will 
be performed by next-generation sequencing and the raw 
data will be analysed using R biostatistical computing plat-
form RStudio GUI. Gene set enrichment analysis will be 
performed to visualise regulated biological processes.37
Epigenetics
Whole-epigenome gene-specific methylation analysis (Illu-
mina EPIC) will be performed on selected samples of the 
placenta, cord blood and blood of children at 48 months 
of age to identify persisting gene-specific changes in DNA 
methylation. Significant DNA methylation markers will be 
validated by pyrosequencing in all children.38 39
Fatty acid and vitamin A and D composition in blood cell 
membranes and plasma
Blood cell fatty acid composition will be analysed in 
unwashed red and white blood cells. Fatty acids from 
blood cells will be extracted40 and analysed using gas 
chromatography-flame ionisation (GC-FID).41 Concen-
trations of vitamin A and D will be determined in plasma 
with liquid chromathography-tandem massspectometry 
(LC-MS/MS).42 43
Determination of toxic metals, other elements and micronutrients
Concentration of toxic and essential elements will be 
measured in serum (Ca, Mg, Zn, Se), erythrocytes (Cd, 
Mn, MeHg, Pb) and urine (As, Cd, U and I) using induc-
tively coupled plasma mass spectrometry (ICP-MS), devel-
oped for high-throughput multiple element analyses.44–46 
Speciation of urinary As (metabolites of inorganic 
arsenic) will be performed by high-performance liquid 
chromatography ICP-MS (HPLC-ICP-MS). Urinary F will 
be measured using an ion-selective electrode.
Oral and gut microbiota analyses
Infant faeces, oral swab and saliva will be collected for 
later analysis of microbiota composition using DNA-based 
sequencing methods.47
data analysis
Most of the questionnaires will be web-based and data will 
be downloaded directly from the surveys to SPSS files. 
All data will be cleaned and entered into a secure data-
base stored within the hospital domain and handled and 
protected with the same confidentiality as patient journal 
data. A statistician at the Unit for Research and Innova-
tion, Department of Development, Region Norrbotten, 
will be responsible for database management. Requests 
from study researchers for analysis of cohort data 
require detailed analysis plan is approved by the steering 
committee. All data transferred to the universities will be 
blinded so that researchers cannot link individual data to 
any specific individual.
Statistical analyses
Univariate and multivariate analysis and data mining, 
including cluster and hierarchical models, will be used, 
depending on data and outcome measures. To examine 
general maternal, paternal and infant demographic data 
and distribution of outcomes, descriptive analysis will be 
Table 5 Overview of research sites involved in the NICE consortium
Institution, Department, Group
Principal investigator of 
the site Main research interests in the NICE cohort
Umeå University, Clinical Sciences, Paediatrics Anna Sandin, MD, PhD, 
Principal Investigator for the 
NICE cohort
Environmental exposures in relation to immune 
maturation and allergy outcomes.
Chalmers University of Technology, Biology 
and Biological Engineering, Food and Nutrition 
Science
Ann-Sofie Sandberg, 
Professor
Nutritional factors in relation to allergy, growth 
and neurological function. Metabolomics to 
predict risk of disease. Systems biology.
Gothenburg University, Clinical Microbiology Agnes Wold, Professor Immune maturation, microbiota and allergy 
development.
Karolinska Institutet, Institute of Environmental 
Medicine
Marie Vahter, Professor Metal exposure and epigenetics in relation to 
growth and neurological function.
Gothenburg University, Sahlgrenska Academy, 
Obstetrics and Gynaecology
Bo Jacobsson, Professor Pregnancy exposures and outcome with special 
interest in placenta.
Umeå University, Department of Odontology/
Cariology
Nicklas Strömberg, 
Professor
Nutritional, immune, microbiota and metal 
factors in caries development.
Karolinska Institutet, Department 
of Women’s and Children’s Health, 
Division of Neuropsychiatry, Centre of 
Neurodevelopmental Disorders (KIND)
Sven Bölte, Professor Neuropsychological and neuropsychiatric 
assessments.
NICE, Nutritional impact on Immunological maturation during Childhood in relation to the Environment. 
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performed initially. Statistical methods linking outcomes 
to collected or measured data will depend on the nature 
of the data: Χ2 tests will be used for categorical data, 
Student’s t-test and analysis of variance (ANOVA) (and 
corresponding non-parametric methods when appli-
cable, such as Mann-Whitney U test and Kruskal-Wallis 
test) for continuous data as well as Pearson's and Spear-
man's correlations. Questionnaire data will be analysed 
by factor analysis to investigate interactions between 
questionnaire variables and identify potential constructs. 
Similar to principal component analysis (PCA), factors/
constructs can be interpreted as latent variables under-
lying observed total data variability. To identify indepen-
dent predictors of outcomes among questionnaire and 
demographic data (both original data and factor scores), 
generalised linear mixed models (ANOVA, logistic 
regressions and conditional logistic regressions) capable 
of controlling for possible confounders will be applied.
Metabolomics data will be generated and preprocessed 
at the Chalmers Mass Spectrometry Infrastructure (www. 
chalmers. se/ en/ rese arch infr astr ucture/ CMSI/ Pages/ 
default. aspx). To identify molecular predictors related 
to outcomes, metabolomics data will be analysed using 
predominantly supervised multivariate methods. We will 
employ partial least squares and random forest techniques 
incorporated into nested cross-validation frameworks to 
effectively manage the high-dimensional nature of untar-
geted metabolomics data. These new techniques also 
perform automatic, unbiased variable selection, suitable for 
identifying biomarkers associated with outcome variables. 
The combined nested cross-validation with unbiased vari-
able selection greatly reduces the risk of false-positive find-
ings while improving modelling accuracy.48 Outputs from 
multivariate models can, as mentioned above, be incorpo-
rated into mixed models to be able to adjust for confounders 
in associations between molecular predictors and outcomes.
Statistical analyses will be performed in two steps: pilot 
analyses and final analyses. Pilot analyses refer to analysis of 
a subset of samples collected during 2015–2016, and final 
analyses refer to data from samples collected from the whole 
study (2015–2018).
Patient and public involvement
The study was based on healthy volunteers. Patients and 
public were neither involved in the design of the study nor 
in the development of the research questions or outcome 
measures. Patients and public were not involved in the 
recruitment or conduction of the study. The results will be 
disseminated to the study participants on a cohort basis on 
yearly workshops. No individual results will be given to the 
participants.
nICE ConsortIuM
steering Committee
The Steering Committee, consisting of MD, PhD, PI Anna 
Sandin, Professor Ann-Sofie Sandberg and Professor 
Agnes Wold, is responsible for administrative and financial 
coordination and monitoring the progress of the cohort. 
The Steering Committee will meet twice a year to handle 
the allocation of resources to the research projects, the 
recruitment of personnel and the scientific direction.
research groups
Research groups involved in the NICE cohort are shown 
in table 5.
Collaborators
Within the NICE cohort, there are close collaborators 
with a range of expertise. For transcriptomics analysis 
and systems biology of the NICE samples, we have a 
close collaboration with Professor Jens Nilsen at Systems 
Biology at the Department of Biology and Biological 
Engineering at Chalmers University of Technology in 
Gothenburg, Sweden. Robert Lundqvist, statistician at 
the Research and Innovation Unit at Region Norrbotten, 
will advise on statistical analyses and will be also respon-
sible for the management of the NICE cohort database.
EthICs And dIssEMInAtIon
The study will be conducted in accordance with the Decla-
ration of Helsinki. The participants will be informed 
about the aims and the requirements of the NICE cohort, 
and will be provided both written and verbal information. 
They will be requested to complete and sign a consent 
form before being enrolled in the study. Once the infant 
is born, the parents will again requested to give consent 
for their child’s participation in the study. All participants 
have the right to withdraw from the study at any point and 
have their data removed from all study documentation.
All data will be securely stored according to Euro-
pean laws and password protected and accessible by the 
research team only. All personal data will be blinded so 
that researchers cannot link individual data to any specific 
individual. Information resulting from the study will be 
disseminated to non-scientific audiences in the region 
where the study has been carried out to keep health 
professionals and interested members of the public 
abreast of the findings. Results from the cohort will be 
disseminated through peer-reviewed journals, preferably 
open access journals to ensure that all readers from the 
scientific society, the clinical professionals as well as the 
general public will have open access to the publication. 
Results will also be communicated by the researchers on 
scientific conferences.
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